Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MP2PRT Genomic and molecular characterization of biomarkers associated with self reported race/ethnicity in high risk endometrial cancers from NRG Oncology/GOG protocol 210, molecular staging of endometrial cancer

ABSTRACT: MP2PRT Genomic and molecular characterization of biomarkers associated with self reported race/ethnicity in high risk endometrial cancers from NRG Oncology/GOG protocol 210, molecular staging of endometrial cancer

PROVIDER: PRJNA850071 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Molecular Biomarkers of Obesity and Metformin Response in Endometrial Cancer: Analysis of GOG-0286B

Project description:Molecular Biomarkers of Obesity and Metformin Response in Endometrial Cancer: Analysis of GOG-0286B

| PRJNA842483 | ENA

Molecular Biomarkers of Obesity and Metformin Response in Endometrial Cancer: Analysis of GOG-0286B

Project description:Molecular Biomarkers of Obesity and Metformin Response in Endometrial Cancer: Analysis of GOG-0286B

| PRJNA842482 | ENA

A molecular staging model for accurately dating the endometrial biopsy [RNA-seq]

Project description:Natural variability in menstrual cycle length, coupled with rapid changes in endometrial gene expression, makes it difficult to accurately define and compare different stages of the endometrial cycle. We have developed and validated a novel method for precisely determining endometrial cycle stage based on global gene expression. Our ‘molecular staging model’ reveals significant and remarkably synchronized daily changes in expression for over 3,400 endometrial genes throughout the cycle, with the most dramatic changes occurring during the secretory phase.

2023-09-06 | GSE234354 | GEO

A molecular staging model for accurately dating the endometrial biopsy

Project description:A molecular staging model for accurately dating the endometrial biopsy

| PRJNA981346 | ENA

A molecular staging model for accurately dating the endometrial biopsy [RNA-seq]

Project description:A molecular staging model for accurately dating the endometrial biopsy [RNA-seq]

| PRJNA981113 | ENA

MP2PRT: Genomic and molecular characterization of biomarkers associated with tumor angiogenesis, DNA repair, and immunologic tolerance using samples from the NRG Oncology Phase 3 Randomized Trial, GOG-0240 (NCT00803062)

Project description:MP2PRT: Genomic and molecular characterization of biomarkers associated with tumor angiogenesis, DNA repair, and immunologic tolerance using samples from the NRG Oncology Phase 3 Randomized Trial, GOG-0240 (NCT00803062)

| PRJNA679645 | ENA

| PRJNA679646 | ENA

Molecular interactions at the bovine embryo–endometrial epithelium interface

Project description:Molecular interactions at the bovine embryo–endometrial epithelium interface

| PRJNA637537 | ENA

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.

Project description:The molecular events implicated in the development of endometrial carcinosarcoma remain poorly understood. Using complementary DNA microarrays, we analyzed a group of 15 endometrial carcinosarcomas and compared their gene expression profiles with those obtained from a group of 23 endometrioid endometrial carcinomas. We demonstrated changes in the expression of genes modulating processes such as the epithelial to mesenchymal transition, muscle differentiation, the expression of cancer/testis antigens, and immune response in endometrial carcinosarcomas. The high mobility group AT-hook 2 gene is an embryonic nuclear factor that mediates epithelial to mesenchymal transition in various tumor models, and it was among the genes overexpressed in endometrial carcinosarcomas. High mobility group AT-hook 2 overexpression was confirmed in 54% of endometrial carcinosarcomas by quantitative real time-polymerase chain reaction and immunohistochemistry. Moreover, we found a significant inverse correlation between the expression of high mobility group AT-hook 2 and let-7b, a member of the let-7 family of microRNAs that represses high mobility group AT-hook 2 expression. These changes were also associated with overexpression of Lin28B, a suppressor of microRNA biogenesis that is implicated in cancer progression and metastasis. Finally, high mobility group AT-hook 2 overexpression, which was detected in less than 3% of endometrioid endometrial carcinomas, was observed in many nonendometrioid carcinomas (46% of 28 samples). This pattern of expression, restricted to nonendometrioid carcinomas and endometrial carcinosarcomas, reflects a role for high mobility group AT-hook 2 in endometrial carcinogenesis that is associated with aggressive phenotypes and points to its potential use as a marker to distinguish between endometrioid and nonendometrioid tumors.

2012-11-01 | GSE33723 | GEO

A molecular staging model for accurately dating the endometrial biopsy

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-09-06 | GSE234434 | GEO